Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias.
Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias. Leuk Res. 2013 Jan; 37(1):93-101.